126 related articles for article (PubMed ID: 38344808)
41. Mitotic centromere-associated kinesin is a novel marker for prognosis and lymph node metastasis in colorectal cancer.
Ishikawa K; Kamohara Y; Tanaka F; Haraguchi N; Mimori K; Inoue H; Mori M
Br J Cancer; 2008 Jun; 98(11):1824-9. PubMed ID: 18506187
[TBL] [Abstract][Full Text] [Related]
42. The kinesin-13 proteins Kif2a, Kif2b, and Kif2c/MCAK have distinct roles during mitosis in human cells.
Manning AL; Ganem NJ; Bakhoum SF; Wagenbach M; Wordeman L; Compton DA
Mol Biol Cell; 2007 Aug; 18(8):2970-9. PubMed ID: 17538014
[TBL] [Abstract][Full Text] [Related]
43. Circular RNA circRGNEF promotes bladder cancer progression via miR-548/KIF2C axis regulation.
Yang C; Li Q; Chen X; Zhang Z; Mou Z; Ye F; Jin S; Jun X; Tang F; Jiang H
Aging (Albany NY); 2020 Apr; 12(8):6865-6879. PubMed ID: 32305958
[TBL] [Abstract][Full Text] [Related]
44. In Silico Analysis of the Correlation of KIF2C with Prognosis and Immune Infiltration in Glioma.
Tu B; Xiang H; Li M; Zhong F; Fang M; Yan W
Comput Math Methods Med; 2022; 2022():6320828. PubMed ID: 35387222
[TBL] [Abstract][Full Text] [Related]
45. Clinicopathological and biological significance of mitotic centromere-associated kinesin overexpression in human gastric cancer.
Nakamura Y; Tanaka F; Haraguchi N; Mimori K; Matsumoto T; Inoue H; Yanaga K; Mori M
Br J Cancer; 2007 Aug; 97(4):543-9. PubMed ID: 17653072
[TBL] [Abstract][Full Text] [Related]
46. Bioinformatical analysis of the key differentially expressed genes for screening potential biomarkers in Wilms tumor.
Cai L; Shi B; Zhu K; Zhong X; Lai D; Wang J; Tou J
Sci Rep; 2023 Sep; 13(1):15404. PubMed ID: 37717078
[TBL] [Abstract][Full Text] [Related]
47. Functional analysis of phosphorylation of the mitotic centromere-associated kinesin by Aurora B kinase in human tumor cells.
Ritter A; Sanhaji M; Friemel A; Roth S; Rolle U; Louwen F; Yuan J
Cell Cycle; 2015; 14(23):3755-67. PubMed ID: 26148251
[TBL] [Abstract][Full Text] [Related]
48. MCAK activity at microtubule tips regulates spindle microtubule length to promote robust kinetochore attachment.
Domnitz SB; Wagenbach M; Decarreau J; Wordeman L
J Cell Biol; 2012 Apr; 197(2):231-7. PubMed ID: 22492725
[TBL] [Abstract][Full Text] [Related]
49. Potent microtubule-depolymerizing activity of a mitotic Kif18b-MCAK-EB network.
McHugh T; Welburn JPI
J Cell Sci; 2023 Mar; 136(5):. PubMed ID: 35502670
[TBL] [Abstract][Full Text] [Related]
50. Gene signatures and prognostic analyses of the Tob/BTG pituitary tumor-transforming gene (PTTG) family in clinical breast cancer patients.
Wu CC; Ekanem TI; Phan NN; Loan DTT; Hou SY; Lee KH; Wang CY
Int J Med Sci; 2020; 17(18):3112-3124. PubMed ID: 33173433
[TBL] [Abstract][Full Text] [Related]
51. Overexpression of forkhead box protein M1 (FOXM1) in ovarian cancer correlates with poor patient survival and contributes to paclitaxel resistance.
Zhao F; Siu MK; Jiang L; Tam KF; Ngan HY; Le XF; Wong OG; Wong ES; Gomes AR; Bella L; Khongkow P; Lam EW; Cheung AN
PLoS One; 2014; 9(11):e113478. PubMed ID: 25411964
[TBL] [Abstract][Full Text] [Related]
52. The activity regulation of the mitotic centromere-associated kinesin by Polo-like kinase 1.
Ritter A; Sanhaji M; Steinhäuser K; Roth S; Louwen F; Yuan J
Oncotarget; 2015 Mar; 6(9):6641-55. PubMed ID: 25504441
[TBL] [Abstract][Full Text] [Related]
53. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
54. Structure-based virtual screening and molecular docking approaches to identify potential inhibitors against KIF2C to combat glioma.
Hussein D; Saka M; Baeesa S; Bangash M; Alghamdi F; Al Zughaibi T; AlAjmi MF; Haque S; Rehman MT
J Biomol Struct Dyn; 2023 Nov; ():1-14. PubMed ID: 37942622
[TBL] [Abstract][Full Text] [Related]
55. The depolymerase activity of MCAK shows a graded response to Aurora B kinase phosphorylation through allosteric regulation.
McHugh T; Zou J; Volkov VA; Bertin A; Talapatra SK; Rappsilber J; Dogterom M; Welburn JPI
J Cell Sci; 2019 Jan; 132(4):. PubMed ID: 30578316
[TBL] [Abstract][Full Text] [Related]
56. Catalysis of the microtubule on-rate is the major parameter regulating the depolymerase activity of MCAK.
Cooper JR; Wagenbach M; Asbury CL; Wordeman L
Nat Struct Mol Biol; 2010 Jan; 17(1):77-82. PubMed ID: 19966798
[TBL] [Abstract][Full Text] [Related]
57. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
58. NY-CO-58/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancer.
Gnjatic S; Cao Y; Reichelt U; Yekebas EF; Nölker C; Marx AH; Erbersdobler A; Nishikawa H; Hildebrandt Y; Bartels K; Horn C; Stahl T; Gout I; Filonenko V; Ling KL; Cerundolo V; Luetkens T; Ritter G; Friedrichs K; Leuwer R; Hegewisch-Becker S; Izbicki JR; Bokemeyer C; Old LJ; Atanackovic D
Int J Cancer; 2010 Jul; 127(2):381-93. PubMed ID: 19937794
[TBL] [Abstract][Full Text] [Related]
59. Prognostic and clinicopathological value of osteopontin expression in non-small cell lung cancer: a meta-analysis and systematic review.
Song Y; Li H; Jiang Q; Wu L
Biomarkers; 2024 Mar; 29(2):105-113. PubMed ID: 38376506
[TBL] [Abstract][Full Text] [Related]
60. Role of
Oh CK; Kang JW; Lee Y; Myung K; Ha M; Kang J; Kwon EJ; Kim Y; Oh SO; Heo HJ; Kim S; Kim YH
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32354205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]